Healthcare Market Research in Ahmedabad

What makes Ahmedabad structurally different from Mumbai or Bengaluru is that its leading hospitals are largely Gujarat-born. Shalby Hospitals — Ahmedabad-headquartered, listed — runs ~17 hospitals and ~2,300 beds and is India's dominant joint-replacement franchise at ~50,000–60,000 replacements a year, with orthopaedics contributing ~35% of revenue; it is now diversifying into cardiac, oncology, neuro and transplants. Zydus Hospitals is part of the Zydus/Cadila pharma group — a pharma-to-provider integration few cities have. CIMS, Sterling and SAL are all strong local multi-specialty brands with deep community trust built over decades.

The incomers are arriving: Apollo Hospitals International (400-bed, JCI + NABH, robotic surgery, transplant); Narayana Multispeciality; and now Mumbai's Lilavati entering via a GIFT City facility — a signal that national brands see Ahmedabad as their next western market. The Adani–Mayo Clinic partnership (~₹6,000 crore) to establish two 1,000-bed multi-specialty hospitals and medical colleges — one in Ahmedabad — brings a global clinical brand and big-capital scale into a market long dominated by local promoters.

The InsightRx read: Ahmedabad is one of the few large markets where local champions still lead and national/international entrants are the challengers — the reverse of most metros. Entry strategy here is about out-positioning entrenched, trusted local brands, not filling empty space. For the national hospital investment context, see our hospital market research India practice, and contrast with the Mumbai and Bengaluru theses — cities where national chains set the terms long ago.